Klaus Buttner
7Patents
0Active
7Granted
29Portfolio score
Filing activity: Sep 29, 1997 → Sep 8, 2004
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6037323A | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 139 | Expired |
| US6046166A | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Human Necessities | 71 | Expired |
| US6734169B2 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 35 | Expired |
| US7189689B2 | Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 11 | Expired |
| US7211565B2 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Chemistry; Metallurgy | 11 | Expired |
| US7273848B2 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Human Necessities | 8 | Expired |
| US7157425B2 | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | Human Necessities | 6 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.